Towards autonomous process control : digital twin for CHO cell-based antibody manufacturing using a dynamic metabolic model

Helgers, Heribert; Schmidt, Axel; Strube, Jochen GND

The development of new biologics is becoming more challenging due to global competition and increased requirements for process understanding and assured quality in regulatory approval. As a result, there is a need for predictive, mechanistic process models. These reduce the resources and time required in process development, generating understanding, expanding the possible operating space, and providing the basis for a digital twin for automated process control. Monoclonal antibodies are an important representative of industrially produced biologics that can be used for a wide range of applications. In this work, the validation of a mechanistic process model with respect to sensitivity, as well as accuracy and precision, is presented. For the investigated process conditions, the concentration of glycine, phenylalanine, tyrosine, and glutamine have been identified as significant influencing factors for product formation via statistical evaluation. Cell growth is, under the investigated process conditions, significantly dependent on the concentration of glucose within the investigated design space. Other significant amino acids were identified. A Monte Carlo simulation was used to simulate the cultivation run with an optimized medium resulting from the sensitivity analysis. The precision of the model was shown to have a 95% confidence interval. The model shown here includes the implementation of cell death in addition to models described in the literature.



Helgers, Heribert / Schmidt, Axel / Strube, Jochen: Towards autonomous process control. digital twin for CHO cell-based antibody manufacturing using a dynamic metabolic model. 2022.


12 Monate:

Grafik öffnen


Nutzung und Vervielfältigung: